Efficacy and safety of udenafil for erectile dysfunction: A meta-analysis of randomized controlled trials

Urology

Volumn 80, Issue 1, 2012, Pages 134-139

  Ding, Hui ^a   Du, Wan ^a   Wang, Hanzhang ^b   Zhang, Liyuan ^a   Wang, Zhiping ^a   Du, Chengwei ^b   Tao, Yan ^a  

^a LANZHOU UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; UDENAFIL;

COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA EXTRACTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EMBASE; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MALE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

EID: 84862992763     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.02.014     Document Type: Article

References (28)

1. F. Montorsi, G. Adaikan, E. Becher Summary of the recommendations on sexual dysfunctions in men J Sex Med 7 2010 3572 3588
2. H.A. Feldman, I. Goldstein, D.G. Hatzichristou Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 151 1994 54 61 (Pubitemid 24046934)
3. K. Hatzimouratidis, E. Amar, I. Eardley Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation Eur Urol 57 2010 804 814
4. J.Y. Dong, Y.H. Zhang, L.Q. Qin Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies J Am Coll Cardiol 58 2011 1378 1385
5. N.V. Chu, S.V. Edelman Erectile dysfunction and diabetes Curr Diab Rep 2 2002 60 66
6. W. Dinsmore, C. Evans ABC of sexual health: erectile dysfunction BMJ 318 1999 387 390 (Pubitemid 29192091)
7. A.L. Burnett, T.F. Lue Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery J Urol 176 2006 882 887 (Pubitemid 44160706)
8. S.H. Francis, J.L. Busch, J.D. Corbin CGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action Pharmacol Rev 62 2010 525 563
9. E.A. Salem, M. Kendirci, W.J. Hellstrom Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction Curr Opin Investig Drugs 7 2006 661 669 (Pubitemid 44018351)
10. J. Higgins, S. Green Cochrane Handbook for Systematic Reviews of Interventions, version 5.0.2 The Cochrane Collaboration 2009 149 190 http://www.cochrane-handbook.org Accessed December 7, 2011
11. C. Zhao, S.W. Kim, D.Y. Yang Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial Eur Urol 60 2011 380 387
12. H.J. Park, J.K. Park, K. Park Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial J Sex Med 7 2010 2209 2216
13. J.S. Paick, S.W. Kim, D.Y. Yang The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction J Sex Med 5 2008 946 953 (Pubitemid 351472204)
14. J.S. Paick, S.W. Kim, Y.K. Park The efficacy and safety of udenafil [Zydena] for the treatment of erectile dysfunction in hypertensive men taking concomitant antihypertensive agents J Sex Med 6 2009 3166 3176
15. G. Moon du, D.Y. Yang, C.H. Lee A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus J Sex Med 8 2011 2048 2061
16. C.C. Carson Erectile dysfunction: evaluation and new treatment options Psychosom Med 66 2004 664 671 (Pubitemid 39332351)
17. P. Hedlund, A. Aszodi, A. Pfeifer Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice Proc Natl Acad Sci USA 97 2000 2349 2354 (Pubitemid 30134072)
18. T.F. Lue Erectile dysfunction N Engl J Med 342 2000 1802 1813 (Pubitemid 30390241)
19. L.J. McDonald, F. Murad Nitric oxide and cyclic GMP signaling Proc Soc Exp Biol Med 211 1996 1 6
20. A.M. Naylor Endogenous neurotransmitters mediating penile erection Br J Urol 81 1998 424 431 (Pubitemid 28316551)
21. M.M. Berner, L. Kriston, A. Harms Efficacy of PDE-5-inhibitors for erectile dysfunction: a comparative meta-analysis of fixed-dose regimen randomized controlled trials administering the International Index of Erectile Function in broad-spectrum populations Int J Impot Res 18 2006 229 235
22. F.A. Giuliano, A. Leriche, E.O. Jaudinot Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both Urology 64 2004 1196 1201 (Pubitemid 39647065)
23. L.E. Fields, V.L. Burt, J.A. Cutler The burden of adult hypertension in the United States 1999 to 2000: a rising tide Hypertension 44 2004 398 404 (Pubitemid 39281486)
24. R. Shabsigh, S. Duval, M. Shah Efficacy of vardenafil for the treatment of erectile dysfunction in men with hypertension: a meta-analysis of clinical trial data Curr Med Res Opin 23 2007 2453 2460 (Pubitemid 350033447)
25. M. Vardi, A. Nini Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus Cochrane Database Syst Rev 2007 CD002187
26. C.B. Johannes, A.B. Araujo, H.A. Feldman Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study J Urol 163 2000 460 463 (Pubitemid 30060493)
27. A. Tsertsvadze, F. Yazdi, H.A. Fink Oral sildenafil citrate (Viagra) for erectile dysfunction: a systematic review and meta-analysis of harms Urology 74 2009 831 836 e838
28. H. Balshem, M. Helfand, H.J. Schünemann GRADE guidelines: 3 Rating the quality of evidence J Clin Epidemiol 64 2011 401 406